the legal battle is currently playing itself out in federal court, the u.s. court of appeals for the fifth circuit, which heard arguments this week on before predictit can keep operating. think of it like sports gambling but on political outcomes. joe biden currently trading at 60 cents a share to be the 2024 democratic nominee. if that happens, people who bought a stake can sell each share for the full dollar. donald trump currently trading at 37 cents per share to be the gop nominee, tied with florida governor ron desantis. by next guest, john aristotle phillips, created predictit, in conjunction with the university of wellington. the federal agency that regulates the markets, the commodity futures trading commission, allowed the market originally with a no action letter, meaning it could run as an academic exercise. so predictit has been operating under restrictions. bets are capped at $850 limits, no mar than 5,000 people can be in any given market at a time.
Appleby Welcomes Jane Walker & Hailee Forde bernews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bernews.com Daily Mail and Mail on Sunday newspapers.
ADELAIDE, Australia, Jan. 23, 2023 /PRNewswire/ Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal and brain tumors. Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a further A$3 million secured via an Australian Government Co-operative Research Centers Project (CRC-P)grant. Existing Ferronova shareholders, led by Uniseed with Artesian Venture Partners also participated. The latest round of funding for the Adelaide, South Australian headquartered company builds on seed capital and Series A funding of $4.6 million. Ferronova Chair Dr John Parker said the international investment from Renew Pharmaceuticals and existing investors, and the CRC-P grant has created a strong platform to accelerate trials in gastrointestinal and brain cancers. "R
/PRNewswire/ Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company s nanoparticle platform to.
ADELAIDE, Australia, Jan. 22, 2023 /PRNewswire/ Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company's nanoparticle platform